Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-009557
Filing Date
2024-12-09
Accepted
2024-12-09 16:28:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 9514
  Complete submission text file 0001950047-24-009557.txt   11003
Mailing Address 3101 WESTERN AVENUE SEATTLE WA 98121
Business Address
Godwin Mary E. (Reporting) CIK: 0001439716 (see all company filings)

Type: 144

Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Subject) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39434 | Film No.: 241535443
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)